Nuveen’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $9.59M | Sell |
|
|||||
|
2023
Q1 | $10.1M | Buy |
|
|||||
|
2022
Q4 | $4.07M | Sell |
|
|||||
|
2022
Q3 | $2.77M | Sell |
|
|||||
|
2022
Q2 | $3.45M | Buy |
|
|||||
|
2022
Q1 | $3.99M | Buy |
|
|||||
|
2021
Q4 | $2.57M | Sell |
|
|||||
|
2021
Q3 | $10.5M | Sell |
|
|||||
|
2021
Q2 | $23.6M | Buy |
|
|||||
|
2021
Q1 | $12.8M | Buy |
|
|||||
|
2020
Q4 | $15.6M | Buy |
|
|||||
|
2020
Q3 | $9.86M | Sell |
|
|||||
|
2020
Q2 | $17.3M | Sell |
|
|||||
|
2020
Q1 | $27.3M | Buy |
|
|||||
|
2019
Q4 | $33.5M | Sell |
|
|||||
|
2019
Q3 | $14M | Buy |
|
|||||
|
2019
Q2 | $12.8M | Buy |
|
|||||
|
2019
Q1 | $412K | Buy |
|